Back
abrdn Life Sciences Investors Vs. Bowman Consulting Group Ltd. Industry Stock Comparison
Buy
63
HQL
abrdn Life Sciences Investors
Last Price:
$16.82
Seasonality Move:
1.06%
Sell
44
BWMN
Bowman Consulting Group Ltd.
Last Price:
$29.63
Seasonality Move:
1.39%
Buy
63
abrdn Life Sciences Investors (HQL)
is a Buy
Is abrdn Life Sciences Investors a Buy, Sell or Hold?
-
The current abrdn Life Sciences Investors [HQL] share price is $16.84. The Score for HQL is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
HQL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Bowman Consulting Group Ltd. (BWMN)
is a Sell
Is Bowman Consulting Group Ltd. a Buy, Sell or Hold?
-
The current Bowman Consulting Group Ltd. [BWMN] share price is $29.65. The Score for BWMN is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
BWMN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HQL Stock Price Chart
What is abrdn Life Sciences Investors's stock price today?
-
The abrdn Life Sciences Investors share price today is $16.84Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HQL is experiencing buying pressure, which is a positive indicator for future bullish movement.
BWMN Stock Price Chart
What is Bowman Consulting Group Ltd.'s stock price today?
-
The Bowman Consulting Group Ltd. share price today is $29.65The current trend is relatively stagnant and BWMN is experiencing buying pressure, which is a positive indicator for future bullish movement.
HQL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 55.98 | Buy |
| Chaikin Money Flow: | 103059 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.09 - 16.69) | Buy |
| Bollinger Bands (100): | (16.44 - 17.22) | Buy |
BWMN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.73 | Sell |
| Relative Strength Index (14 RSI): | 49.61 | Sell |
| Chaikin Money Flow: | 51978 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.4 - 31.18) | Buy |
| Bollinger Bands (100): | (30.57 - 35.89) | Sell |
HQL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.42 | Buy |
| 20-day SMA: | 16.42 | Buy |
| 50-day SMA: | 16.71 | Buy |
| 200-day SMA: | 15.6 | Buy |
| 8-day EMA: | 16.49 | Buy |
| 20-day EMA: | 16.46 | Buy |
| 50-day EMA: | 16.58 | Buy |
| 200-day EMA: | 15.83 | Buy |
BWMN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.98 | Buy |
| 20-day SMA: | 28.55 | Buy |
| 50-day SMA: | 31.74 | Sell |
| 200-day SMA: | 35.62 | Sell |
| 8-day EMA: | 28.94 | Buy |
| 20-day EMA: | 29.27 | Buy |
| 50-day EMA: | 31.11 | Sell |
| 200-day EMA: | 33.16 | Sell |
abrdn Life Sciences Investors Earnings Growth & HQL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bowman Consulting Group Ltd. Earnings Growth & BWMN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.09 per share, and an increase next year of $0.56 per share.
abrdn Life Sciences Investors Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bowman Consulting Group Ltd. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||